Mexico approves emergency use of Pfizer's COVID-19 pills - Market News
Home » Mexico approves emergency use of Pfizer’s COVID-19 pills
Covid-19

Mexico approves emergency use of Pfizer’s COVID-19 pills

Mexico approves emergency use of Pfizer's COVID-19 pills

Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is manufactured in Ascoli, Italy, seen in this undated handout photo obtained by Reuters on Nov. 16, 2021. Pfizer/Handout via REUTERS

MEXICO CITY, Jan. 14 (Reuters) – Mexican health regulator COFEPRIS said on Friday that it has approved U.S. pharmaceutical company Pfizer’s (PFE.N) oral antiviral treatment against COVID-19 for emergency use in adults at low or moderate risk of complications.

Paxlovid, which combines nirmatrelvir and ritonavir in a tablet, requires a prescription, a statement said.

The treatment was nearly 90% effective in preventing hospitalizations and deaths, and data suggested it retains its effectiveness against the Omicron variant, Pfizer said:.

At the end of last year, COFEPRIS had a similar treatment approved by Eli Lilly and Co (LLY.N).

Register now for FREE unlimited access to Reuters.com

Reporting by Mexico City Newsroom

Our standards: The Thomson Reuters Trust Principles.